Hepatocellular carcinoma (HCC or hepatoma) is the most common primary liver malignancy. Chronic hepatic inflammation is the major driving factor in the development of HCC. Risk factors vary by regional exposures. As chronic Hepatitis B virus (HBV) infection is the most common risk factor leading ...
Liver. In: Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. Table 9-2 Staging Classification for Hepatocellular Carcinoma T1 tumor stage classification is for all solitary tumors regardless of size without vascular invasion (Figure 9-...
Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Imaging is important for establishing a diagnosis of HCC. Several imaging modalitie... Tiffany,Hennedige,S Kundapur,... - 《Cancer Imaging the Official Publication of the International Cancer Imaging Society》 被引量: 125发表...
Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulation Snaebjornsson et al. explore a selective vulnerability in cancer elicited by targeting aldolase A, which causes energy imbalance and prevents further metabolic adaptations. ...
Vitamin C (L-ascorbic acid, ascorbate, VC) is a potential chemotherapeutic agent for cancer patients. However, the anti-tumor effects of pharmacologic VC on hepatocellular carcinoma (HCC) and liver cancer stem cells (CSCs) remain to be fully elucidated. Panels of human HCC cell lines as well...
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver. Hepatocellular carcinoma is now the third leading cause of cancer deaths worldwide, with over 500,000 people affected.
Currently, liver transplantation stands as the best treatment modality for early-stage hepatocellular carcinoma in patients with decompensated cirrhosis, giving patients the opportunity to be free from the potentially lethal complications from both cancer and their advanced underlying liver disease. Following...
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a leading cause of cancer-related death worldwide. It is highly refractory to most systemic therapies. Recently, significant progress has been made in uncovering genomic alterations in HCC, including potentially targetabl...
Liver cancer: translating `-omics' results into precision medicine for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2017;14:571-2.Liver cancer:Translating’’-omics’’results into precision medicine for hepatocellular carcinoma. Sia D,Llovet JM. Nat Rev Gastroenterol Hepatol . 2017...
Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for ~90% of cases. Infection by hepatitis B virus and hepatiti